Health & WellnessTech
CannabisPeople of ColorWomen

BioSmart Research, Inc.

BioSmart Research: nutraceutical CBD isolates for professional distribution.
Investment type:
(Convertible Note)
Target raise:
 - $1,070,000
Minimum investment:​
End date:
May 01, 2022
Share on facebook
Share on twitter
Share on linkedin
Share on email

  • Launch in 2019 produced $1.7M in sales
  • Biosmart produces pain management and anti-anxiety formulas for clinical and retail distribution
  • BioSmart has a 3-year technology lead using high-pressure liquid chromatography for isolate extraction
  • BioSmart markets through it’s own retail dispensaries, healthcare providers, pharmacies, affiliates, and internet sales
Our Story

BioSmart Research produces CBD isolate formulas for topical and internal use
Our Ambition

BioSmart Research should have no less than 50 retail dispensaries and 500 professional partners consisting of retailers, pain clinics, pharmacies, and physical therapy businesses producing $25 million in sales per year. These projections cannot be guaranteed.